Toll Free: 1-888-928-9744

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016

Published: Mar 11, 2016 | Pages: 114 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Glaucoma Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Glaucoma Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Glaucoma Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons To Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Glaucoma Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
1 Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 9 2 Introduction 10 2.1 Glaucoma Surgery Devices Overview 10 3 Products under Development 11 3.1 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11 3.2 Glaucoma Surgery Devices - Pipeline Products by Segment 12 3.3 Glaucoma Surgery Devices - Pipeline Products by Territory 13 3.4 Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14 3.5 Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15 3.6 Glaucoma Surgery Devices - Ongoing Clinical Trials 16 4 Glaucoma Surgery Devices - Pipeline Products under Development by Companies 17 4.1 Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 17 4.2 Glaucoma Surgery Devices - Pipeline Products by Stage of Development 19 5 Glaucoma Surgery Devices Companies and Product Overview 21 5.1 Allergan Plc Company Overview 21 5.1.1 Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 21 5.2 Anteis S.A. Company Overview 25 5.2.1 Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview 25 5.3 Assenti, LLC Company Overview 26 5.3.1 Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 26 5.4 Camras Vision Company Overview 27 5.4.1 Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 27 5.5 Ellex Medical Lasers Limited Company Overview 28 5.5.1 Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 28 5.6 Eye Sonix Company Overview 29 5.6.1 Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 29 5.7 Galaxy Ophthalmics Inc Company Overview 30 5.7.1 Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 30 5.8 Geuder AG Company Overview 31 5.8.1 Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 31 5.9 Glaukos Corporation Company Overview 33 5.9.1 Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview 33 5.10 InnFocus LLC Company Overview 41 5.10.1 InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 41 5.11 IPI Singapore Company Overview 44 5.11.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 44 5.12 iSTAR Medical Company Overview 45 5.12.1 iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 45 5.13 Ivantis, Inc. Company Overview 47 5.13.1 Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47 5.14 Konan Medical Inc. Company Overview 51 5.14.1 Konan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51 5.15 Kytogenics Pharmaceuticals, Inc. Company Overview 54 5.15.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54 5.16 Massachusetts Eye and Ear Infirmary Company Overview 55 5.16.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 55 5.17 Medtronic plc Company Overview 56 5.17.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56 5.18 Meir Medical Center Company Overview 58 5.18.1 Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 58 5.19 MicroOptx, Inc. Company Overview 59 5.19.1 MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59 5.20 Ocular Therapeutix, Inc. Company Overview 60 5.20.1 Ocular Therapeutix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60 5.21 Oculox Technology Sagl Company Overview 62 5.21.1 Oculox Technology Sagl Pipeline Products & Ongoing Clinical Trials Overview 62 5.22 Ocumatrx Company Overview 63 5.22.1 Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 63 5.23 OcuTherix, Inc. Company Overview 64 5.23.1 OcuTherix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64 5.24 OPKO Health, Inc. Company Overview 65 5.24.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65 5.25 OptoLight Vision Technology Company Overview 67 5.25.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 67 5.26 PolyActiva Pty Ltd Company Overview 69 5.26.1 PolyActiva Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 69 5.27 Queen's University Company Overview 70 5.27.1 Queen's University Pipeline Products & Ongoing Clinical Trials Overview 70 5.28 Refocus Group, Inc. Company Overview 71 5.28.1 Refocus Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71 5.29 SOLX, Inc. Company Overview 73 5.29.1 SOLX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73 5.30 Tel Aviv University Company Overview 76 5.30.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 76 5.31 TonoGuard Ltd. Company Overview 78 5.31.1 TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78 5.32 Transcend Medical, Inc. Company Overview 79 5.32.1 Transcend Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79 5.33 University of Rostock Company Overview 82 5.33.1 University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 82 5.34 ViSci Ltd. Company Overview 83 5.34.1 ViSci Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83 5.35 Westhouse Medical Services Plc Company Overview 84 5.35.1 Westhouse Medical Services Plc Pipeline Products & Ongoing Clinical Trials Overview 84 6 Glaucoma Surgery Devices- Recent Developments 85 7 Appendix 111 7.1 Methodology 111 7.2 About GlobalData 113 7.3 Contact Us 114 7.4 Disclaimer 114
List of Tables
Table 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11 Table 2: Glaucoma Surgery Devices - Pipeline Products by Segment 12 Table 3: Glaucoma Surgery Devices - Pipeline Products by Territory 13 Table 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14 Table 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15 Table 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 16 Table 7: Glaucoma Surgery Devices Companies - Pipeline Products by Stage of Development 17 Table 8: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 19 Table 9: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 21 Table 10: XEN45 - Product Status 22 Table 11: XEN45 - Product Description 22 Table 12: Allergan Plc - Ongoing Clinical Trials Overview 23 Table 13: XEN45 - A Prospective, Multicenter Clinical Trial Designed to Evaluate the Safety and Performance of the AqueSys XEN 45 Glaucoma Implant in Subjects with Refractory Glaucoma 24 Table 14: XEN45 - Ab Interno Gelatin Stent with Mitomycin-C Combined with Cataract Surgery for Treatment of Open-angle Glaucoma 24 Table 15: XEN45 - Post Market Multicentric Evaluation of the AqueSys XEN Implant in Moderate Primary Open Angle Glaucoma Subjects 24 Table 16: Anteis S.A. Pipeline Products & Ongoing Clinical Trials Overview 25 Table 17: Drainage Viscoelastic Injectable Implant - Product Status 25 Table 18: Drainage Viscoelastic Injectable Implant - Product Description 25 Table 19: Assenti, LLC Pipeline Products & Ongoing Clinical Trials Overview 26 Table 20: Intraocular Pressure Monitoring System - Product Status 26 Table 21: Intraocular Pressure Monitoring System - Product Description 26 Table 22: Camras Vision Pipeline Products & Ongoing Clinical Trials Overview 27 Table 23: Camras Shunt - Product Status 27 Table 24: Camras Shunt - Product Description 27 Table 25: Ellex Medical Lasers Limited Pipeline Products & Ongoing Clinical Trials Overview 28 Table 26: Glaucoma Device - Product Status 28 Table 27: Glaucoma Device - Product Description 28 Table 28: Eye Sonix Pipeline Products & Ongoing Clinical Trials Overview 29 Table 29: Therapeutic Ultrasound Device - Glaucoma - Product Status 29 Table 30: Therapeutic Ultrasound Device - Glaucoma - Product Description 29 Table 31: Galaxy Ophthalmics Inc Pipeline Products & Ongoing Clinical Trials Overview 30 Table 32: Implantable Glaucoma Therapy Device - Product Status 30 Table 33: Implantable Glaucoma Therapy Device - Product Description 30 Table 34: Geuder AG Pipeline Products & Ongoing Clinical Trials Overview 31 Table 35: MikroAug - Product Status 32 Table 36: MikroAug - Product Description 32 Table 37: Glaukos Corporation Pipeline Products & Ongoing Clinical Trials Overview 33 Table 38: GTS400 - Product Status 34 Table 39: GTS400 - Product Description 34 Table 40: iStent Inject - Cataract Surgery - Product Status 35 Table 41: iStent Inject - Cataract Surgery - Product Description 35 Table 42: iStent Inject - Standalone Procedures - Product Status 36 Table 43: iStent Inject - Standalone Procedures - Product Description 36 Table 44: iStent Supra - Product Status 37 Table 45: iStent Supra - Product Description 37 Table 46: Glaukos Corporation - Ongoing Clinical Trials Overview 38 Table 47: iStent Supra - A Prospective Evaluation of Open-angle Glaucoma Subjects with One Prior Trabeculectomy Treated Concurrently with One Suprachoroidal Stent and Two Trabecular Micro-bypass Stents and a Postoperative Prostaglandin 39 Table 48: iStent Supra - A Prospective, Randomized, Controlled, Parallel Groups Evaluation of Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment with Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty 39 Table 49: iStent Inject - Cataract Surgery - A Prospective Evaluation of Open-angle Glaucoma Subjects on One Topical Hypotensive Medication Randomized to Treatment with One or Two Trabecular Micro-bypass Stents in Conjunction with Cataract Surgery 40 Table 50: iStent Inject - Cataract Surgery - A Prospective, Randomized, Single-masked, Controlled, Parallel Groups, Multicenter Clinical Investigation of the Glaukos Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction with Cataract Surgery 40 Table 51: InnFocus LLC Pipeline Products & Ongoing Clinical Trials Overview 41 Table 52: InnFocus Microshunt - Product Status 41 Table 53: InnFocus Microshunt - Product Description 41 Table 54: InnFocus LLC - Ongoing Clinical Trials Overview 42 Table 55: InnFocus Microshunt - InnFocus MicroShunt FDA clinical trial 43 Table 56: InnFocus Microshunt - Post Market Study to Evaluate Safety and Effectiveness of the InnFocus Microshunt (MIDI Arrow) in Patients with Primary Open Angle Glaucoma 43 Table 57: InnFocus Microshunt - Safety and Performance of Miami InnFocus Drainage Implant (MIDI Arrow) to Relieve Glaucoma Symptoms 43 Table 58: IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 44 Table 59: Pressure-Sensitive Glaucoma Drainage Device - Product Status 44 Table 60: Pressure-Sensitive Glaucoma Drainage Device - Product Description 44 Table 61: iSTAR Medical Pipeline Products & Ongoing Clinical Trials Overview 45 Table 62: STARflo MINI - Product Status 45 Table 63: STARflo MINI - Product Description 45 Table 64: STARflo Plus Glaucoma Implant - Product Status 46 Table 65: STARflo Plus Glaucoma Implant - Product Description 46 Table 66: Ivantis, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47 Table 67: Hydrus Microstent - Product Status 47 Table 68: Hydrus Microstent - Product Description 47 Table 69: Ivantis, Inc. - Ongoing Clinical Trials Overview 48 Table 70: Hydrus Microstent - A Prospective, Multi-center, Randomized Controlled Trial to Evaluate the Safety and Effectiveness of the Hydrus Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 49 Table 71: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery 49 Table 72: Hydrus Microstent - A Prospective, Multicenter, Randomized Comparison of the Hydrus to the iStent for Lowering Intraocular Pressure in Primary Open Angle Glaucoma 50 Table 73: Hydrus Microstent - The Safety and Effectiveness of the Hydrus Aqueous Implant for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery, A Prospective, Multicenter, Randomized, Controlled Clinical Trial 50 Table 74: Konan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51 Table 75: Bionocular Analytic Dynamic Pupillometer - Product Status 51 Table 76: Bionocular Analytic Dynamic Pupillometer - Product Description 51 Table 77: Konan Medical Inc. - Ongoing Clinical Trials Overview 52 Table 78: Bionocular Analytic Dynamic Pupillometer - The Detection of Glaucoma Using Pupillography 53 Table 79: Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54 Table 80: MACC-Based Device - Glaucoma Filtering - Product Status 54 Table 81: MACC-Based Device - Glaucoma Filtering - Product Description 54 Table 82: Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 55 Table 83: Pressure Relief Valve Shunt - Product Status 55 Table 84: Pressure Relief Valve Shunt - Product Description 55 Table 85: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 56 Table 86: CellPlant - Product Status 57 Table 87: CellPlant - Product Description 57 Table 88: Meir Medical Center Pipeline Products & Ongoing Clinical Trials Overview 58 Table 89: Glaucoma Drainage Device - Product Status 58 Table 90: Glaucoma Drainage Device - Product Description 58 Table 91: MicroOptx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59 Table 92: BG Implant Shunt - Product Status 59 Table 93: BG Implant Shunt - Product Description 59 Table 94: Ocular Therapeutix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60 Table 95: Travoprost Punctum Plug - Product Status 61 Table 96: Travoprost Punctum Plug - Product Description 61 Table 97: Oculox Technology Sagl Pipeline Products & Ongoing Clinical Trials Overview 62 Table 98: Foldable Intraocular Pressure Sensor Device - Product Status 62 Table 99: Foldable Intraocular Pressure Sensor Device - Product Description 62 Table 100: Ocumatrx Pipeline Products & Ongoing Clinical Trials Overview 63 Table 101: CaPRI Device - Product Status 63 Table 102: CaPRI Device - Product Description 63 Table 103: OcuTherix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64 Table 104: Deep Wave Trabeculoplasty Device - Product Status 64 Table 105: Deep Wave Trabeculoplasty Device - Product Description 64 Table 106: OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65 Table 107: Aquashunt - Product Status 66 Table 108: Aquashunt - Product Description 66 Table 109: OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview 67 Table 110: Lipshitz Macular Implant For Advanced Glaucoma - Product Status 68 Table 111: Lipshitz Macular Implant For Advanced Glaucoma - Product Description 68 Table 112: PolyActiva Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 69 Table 113: Fully Bioerodible Ocular Implant - Glaucoma - Product Status 69 Table 114: Fully Bioerodible Ocular Implant - Glaucoma - Product Description 69 Table 115: Queen's University Pipeline Products & Ongoing Clinical Trials Overview 70 Table 116: Laser Adjustable Suture - Product Status 70 Table 117: Laser Adjustable Suture - Product Description 70 Table 118: Refocus Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71 Table 119: PresVIEW Scleral Implant - Glaucoma - Product Status 72 Table 120: PresVIEW Scleral Implant - Glaucoma - Product Description 72 Table 121: SOLX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73 Table 122: SOLX Gold Shunt - Product Status 73 Table 123: SOLX Gold Shunt - Product Description 73 Table 124: SOLX, Inc. - Ongoing Clinical Trials Overview 74 Table 125: SOLX Gold Shunt - Clinical Evaluation of the SOLX Gold Shunt for the Reduction of Intraocular Pressure (IOP) in Refractory Glaucoma 75 Table 126: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 76 Table 127: Direct Laser Trabeculoplasty System - Product Status 76 Table 128: Direct Laser Trabeculoplasty System - Product Description 76 Table 129: Glaucoma Implant - Product Status 77 Table 130: Glaucoma Implant - Product Description 77 Table 131: TonoGuard Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78 Table 132: EasyIOP - Product Status 78 Table 133: EasyIOP - Product Description 78 Table 134: Transcend Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79 Table 135: CyPass Micro-Stent - Product Status 79 Table 136: CyPass Micro-Stent - Product Description 79 Table 137: Transcend Medical, Inc. - Ongoing Clinical Trials Overview 80 Table 138: CyPass Micro-Stent - A Randomized, Prospective Clinical Evaluation of the Safety and Effectiveness of Visco-assisted CyPass Micro-Stent Implantation in Patients with Open Angle Glaucoma 81 Table 139: University of Rostock Pipeline Products & Ongoing Clinical Trials Overview 82 Table 140: PTX-Eluting Microstent - Product Status 82 Table 141: PTX-Eluting Microstent - Product Description 82 Table 142: ViSci Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83 Table 143: Sub-Conjunctival Drug Implant - Product Status 83 Table 144: Sub-Conjunctival Drug Implant - Product Description 83 Table 145: Westhouse Medical Services Plc Pipeline Products & Ongoing Clinical Trials Overview 84 Table 146: Pneumatic Trabeculoplasty System - Product Status 84 Table 147: Pneumatic Trabeculoplasty System - Product Description 84 Table 148: Glossary 112


List of Figures
Figure 1: Glaucoma Surgery Devices - Pipeline Products by Stage of Development 11 Figure 2: Glaucoma Surgery Devices - Pipeline Products by Segment 12 Figure 3: Glaucoma Surgery Devices - Pipeline Products by Territory 13 Figure 4: Glaucoma Surgery Devices - Pipeline Products by Regulatory Path 14 Figure 5: Glaucoma Surgery Devices - Pipeline Products by Estimated Approval Date 15 Figure 6: Glaucoma Surgery Devices - Ongoing Clinical Trials 16

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehi

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...

Global microcontroller market is estimated to be valued at USD 26.9 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing demand in key application areas such as automotive, consumer electronics and healthcare is expected to

Read More...
Choose License Type
Single User - US $4000
Multi User - US $8000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify